Pages that link to "Item:Q3837320"

The following pages link to Consistency of continual reassessment method under model misspecification (Q3837320):

Displaying 27 items.

• A note on the robustness of the continual reassessment method (Q433569) (← links)
• On the consistency of the continual reassessment method with multiple toxicity constraints (Q499432) (← links)
• The treatment versus experimentation dilemma in dose finding studies (Q538132) (← links)
• Stochastic approximation and modern model-based designs for dose-finding clinical trials (Q903289) (← links)
• Convergence properties of sequential Bayesian \(D\)-optimal designs (Q958799) (← links)
• Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity (Q2441853) (← links)
• Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
• Theoretical study of the continual reassessment method (Q2492919) (← links)
• Dose-Finding Designs for HIV Studies (Q3078854) (← links)
• On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance (Q3078934) (← links)
• Curve-Free and Model-Based Continual Reassessment Method Designs (Q3078936) (← links)
• A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method (Q3079010) (← links)
• Continual Reassessment Method for Ordered Groups (Q3079132) (← links)
• Dynamic calibration of pharmacokinetic parameters in dose-finding studies (Q3303574) (← links)
• Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities (Q4670477) (← links)
• (Q4998881) (← links)
• (Q5072154) (← links)
• A new design of the continual reassessment method (Q5082671) (← links)
• A study of the probit model with latent variables in Phase I clinical trials (Q5220814) (← links)
• Retrospective Analysis of Sequential Dose‐Finding Designs (Q5717156) (← links)
• Performance Measures in Dose‐Finding Experiments (Q6085864) (← links)
• Statistical frameworks for oncology dose-finding designs with late-onset toxicities: a review (Q6577811) (← links)
• A simulation-free approach to assessing the performance of the continual reassessment method (Q6617412) (← links)
• Incorporating patient-reported outcomes in dose-finding clinical trials (Q6627303) (← links)
• Consistency of the when the curve is not monotone and its application to the POCRM (Q6627746) (← links)
• Change-point joint model for identification of plateau of activity in early phase trials (Q6627755) (← links)
• Comment on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies'' (Q6629389) (← links)